Oruka Therapeutics, Inc. (ORKA) Investor Relations Documents

Oruka Therapeutics, Inc. (ORKA) investor relations documents from the company's IR site: 3 presentations, 15 press releases; latest deck 2026-08-24. Read in-app with summaries. First-party data.

PDF Version: Oruka Therapeutics appointed Todd Edwards chief commercial officer effective August 24, 2026, to help advance ORKA-001 and ORKA-002 toward commercialization.

Investor relations documents — source: company IR site
PublishedTypeDocument
2026-08-24PresentationPDF Version
2026-08-24Press releaseOruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer
2026-08-10PresentationCorporate Presentation
2026-08-10Press releaseOruka Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
2026-06-23Press releasePDF Version
2026-05-28Press releaseOruka Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
2026-05-13Press releaseOruka Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
2026-05-06Press releaseHalozyme and Oruka Announce Global Collaboration and License Agreement to Develop ORKA-001 with Hypercon™ Technology
2026-04-28Press releaseOruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
2026-04-27PresentationInterim EVERLAST-A Data Presentation
2026-04-27Press releaseOruka Therapeutics Announces Proposed $500 Million Underwritten Public Offering
2026-04-27Press releaseOruka Therapeutics Announces Positive Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Phase 2a Trial in Moderate-t
2026-04-27Press releaseOruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on Apri
2026-03-12Press releaseOruka Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
2026-02-09Press releaseOruka Therapeutics to Participate in Multiple Upcoming Conferences
2026-01-12Press releasePDF Version
2026-01-06Press releasePDF Version
2026-01-06Press releaseOruka Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

ORKA overview · ORKA earnings · ORKA financials · ORKA KPIs · ORKA documents · ORKA ownership · ORKA peers

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.